Asmanex Twisthaler is a brand name of mometasone, approved by the FDA in the following formulation(s):
ASMANEX TWISTHALER (mometasone furoate - powder; inhalation)
Manufacturer: SCHERING
Approval date: March 30, 2005
Strength(s): 0.22MG/INH [RLD]
Manufacturer: SCHERING
Approval date: February 1, 2008
Strength(s): 0.11MG/INH
Has a generic version of Asmanex Twisthaler been approved?
No. There is currently no therapeutically equivalent version of Asmanex Twisthaler available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Asmanex Twisthaler. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Related Patents
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Inhalation device for powdered medicaments
Patent 5,394,868
Issued: March 7, 1995
Inventor(s): Ambrosio; Thomas J. & Manthena; Srinivas & Sochon; Henry R.
Assignee(s): Schering Corporation
A powder dispenser 10 includes a powder housing 28 for holding a supply of powdered material to be dispensed, the powder housing including a first conduit 32 extending there through in displaced relation to the powdered material; a metering plate 16 having only a single receptacle area 24 for holding a metered amount of the powdered material above a gas-permeable powder retainer 26 mounted at the metering plate, and being positioned below the powdered material, and the metering plate and the powder housing being rotatable with respect to each other so that the receptacle area is adapted to be in selective communication with the supply of powdered material or the first conduit; a base housing 48 being mounted below the metering plate and including a second conduit 52 in alignment with the first conduit at least concurrently with alignment of the receptacle area and the first conduit; a spring 62 for biasing the base housing and the powder housing toward each other; a mouthpiece 92 for enabling inhalation of the metered amount of powdered material from the receptacle area in the metering plate through the first conduit in the container, the mouthpiece being in fluid communication with the first conduit.Patent expiration dates:
- June 25, 2012✓
- December 25, 2012✓
- June 25, 2012
Inhaler for powdered medications having spiral deagglomeration chamber
Patent 5,687,710
Issued: November 18, 1997
Inventor(s): Ambrosio; Thomas J. & Bilanin; Alan J. & Kaufman; Andrew E. & Kenyon; David J. & Manthena; Srinivas & Yang; Tsong-Toh
Assignee(s): Schering Corporation
A powder dispenser includes a powder housing for holding a supply of powdered material to be dispensed, the powder housing including an inhalation conduit provided displaced relation to the powdered material supply; a metering plate including a metered dose hole for holding a metered amount of the powdered material, and positioned below the powdered material supply, the metering plate and the powder housing being relatively rotatable with respect to each other about a common central axis; a counter providing a visual count of the number of doses of the powdered material that have been dispensed or remain to be dispensed in response to the relative rotation, the counter including counter rings providing the visual count, the counter rings being rotatable about the common central axis and having indicia thereon which display the visual count, and an actuating mechanism rotatable about the central axis for incrementally rotating the counter rings in response to the relative rotation; a nozzle for breaking up agglomerates of powdered material from the inhalation conduit to form micronized powdered material, the nozzle including a cavity for changing the direction of flow of the powder from the direction of the inhalation conduit to a second different direction, and a curved wall for substantially continuously changing the direction of flow of the powder in a spiral manner in the second direction in the cavity; and a closure cap covering the powder housing and priming the powder dispenser for use automatically upon removal thereof.Patent expiration dates:
- November 18, 2014✓
- May 18, 2015✓
- November 18, 2014
Inhaler for powdered medications
Patent 5,829,434
Issued: November 3, 1998
Inventor(s): Ambrosio; Thomas J. & Ashley; Charles R. & Bilanin; Alan J. & Huck; Charles M. & Kaufman; Andrew E. & Kenyon; David J. & Manthena; Srinivas & Sochon; Henry R. & Wilkinson; Ken & Yang; Tsong-Toh
Assignee(s): Schering Corporation
A powder inhaler comprising: a powder housing for holding a supply of powdered material to be dispensed and a metering plate for holding a metered amount of said powdered material, the metering plate being alternately positionable below said supply of powdered material or within an inhalation conduit, by means of a bi-directional, angle-limited relative rotation about a common central axis; a counter for providing a visual count of the number of doses of said powdered material that have been dispensed or remain to be dispensed in response to the relative rotation, the counter including: a continuous counter ring and a coaxially mounted intermittent counter ring, both rings being mounted on a base in surrounding relation to a retaining post, being rotatable about the common central axis and having counting indicia thereon for displaying said visual count; and a display means through which at least one of the counting indicia is displayed to indicate a count corresponding to a number of doses of powdered material that have been dispensed or remain to be dispensed.Patent expiration dates:
- November 3, 2015✓
- May 3, 2016✓
- November 3, 2015
Use of mometasone furoate for treating lower airway passage and lung diseases
Patent 5,889,015
Issued: March 30, 1999
Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
Assignee(s): Schering Corporation
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.Patent expiration dates:
- January 27, 2014✓
- July 27, 2014✓
- January 27, 2014
Use of mometasone furoate for treating airway passage and lung diseases
Patent 6,057,307
Issued: May 2, 2000
Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
Assignee(s): Schering Corporation
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.Patent expiration dates:
- January 27, 2014✓✓
- July 27, 2014✓
- January 27, 2014
Powdered medication inhaler
Patent 6,240,918
Issued: June 5, 2001
Inventor(s): Ambrosio; Thomas J. & Benson, Jr.; Warren A. & Dao; Kim C. & Kenyon; David J. & Kreiseder; Walter J. & Schonebaum; Theodore J. & Vogel; Allen J. & Walker; Louis B. & Yang; Tsong-Toh
Assignee(s): Schering Corporation
A powder dispenser includes a reservoir body including a supply of powder and an inhalation conduit; a driving body for rotating the reservoir body and including upper recesses and two spring fingers in lower driving recesses thereof; a rotatable metering plate for carrying a metered amount of powder from the supply to the inhalation conduit, and having an underside with ribs; a gas permeable retainer welded to the ribs; a spring biasing the metering plate toward the reservoir body; a nozzle having spiked ribs welded in the upper recesses of the driving body and including a chimney with vertical flutes; an adapter non-rotatably mounted with respect to the metering plate and including two locking recesses for receiving the spring fingers for locking engagement and two helical cam tracks with a square cross-section; a closure cap covering the driving body and including priming ribs biasing the spring fingers out of the locking recesses and engaging with the locking recesses to rotate the driving body, and two cams riding within the cam tracks; a base non-rotatably connected with the metering plate; and a counter rotatably mounted on the base and including rotatable counter rings providing a visual count of the number of doses of powder to be dispensed, and a pawl assembly engaging with gear teeth of the counter rings for rotating the same, the pawl assembly including an outer wall, a pawl and a pawl spring integrally molded as a single piece.Patent expiration dates:
- February 20, 2017✓
- August 20, 2017✓
- February 20, 2017
Use of mometasone furoate for treating airway passage and lung diseases
Patent 6,365,581
Issued: April 2, 2002
Inventor(s): Joel A.; Sequeira & Francis M.; Cuss & Keith B.; Nolop & Imtiaz A.; Chaudry & Nagamani; Nagabhushan & James E.; Patrick & Mitchell; Cayen
Assignee(s): Schering Corporation
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.Patent expiration dates:
- January 27, 2014✓
- July 27, 2014✓
- January 27, 2014
Preparation of powder agglomerates
Patent 6,503,537
Issued: January 7, 2003
Inventor(s): Tsong-Toh; Yang
Assignee(s): Schering Corporation
The invention relates to a method of producing an agglomerate of drug and solid binder. The process involves producing individual agglomerate particles and then converting the convertible amorphous content of same, following agglomeration, by the application of, for example, moisture. Agglomerates capable of conversion as well as the finished agglomerates and oral and nasal dosing systems including same are also contemplated. The process produces agglomerates which are rugged but which will produce an acceptable fine particle fraction during dosing.Patent expiration dates:
- March 17, 2018✓
- September 17, 2018✓
- March 17, 2018
Use of mometasone furoate for treating airway passage and lung diseases
Patent 6,677,322
Issued: January 13, 2004
Inventor(s): Joel A.; Sequeira & Francis M.; Cuss & Keith B.; Nolop & Imtiaz A.; Chaudry & Nagamani; Nagabhushan & James E.; Patrick & Mitchell; Cayen
Assignee(s): Schering Corporation
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.Patent expiration dates:
- January 27, 2014✓
- July 27, 2014✓
- January 27, 2014
Use of mometasone furoate for treating airway passage and lung diseases
Patent 6,949,532
Issued: September 27, 2005
Inventor(s): Sequeira; Joel A. & Cuss; Francis M. & Nolop; Keith B. & Chaudry; Imtiaz A. & Nagabhushan; Nagamani & Patrick; James E. & Cayen; Mitchell
Assignee(s): Schering Corporation
The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.Patent expiration dates:
- January 27, 2014✓
- July 27, 2014✓
- January 27, 2014
Related Exclusivities
Exclusivity is exclusive marketing rights granted by the FDA upon approval of a drug and can run concurrently with a patent or not. Exclusivity is a statutory provision and is granted to an NDA applicant if statutory requirements are met.
- Exclusivity expiration dates:
- February 1, 2011 - NEW PATIENT POPULATION
See also...
- Asmanex Consumer Information (Drugs.com)
- Asmanex Twisthaler Powder Consumer Information (Wolters Kluwer)
- Asmanex Twisthaler 120 Dose Consumer Information (Cerner Multum)
- Asmanex Twisthaler 14 Dose Consumer Information (Cerner Multum)
- Asmanex Twisthaler 30 Dose Consumer Information (Cerner Multum)
- Asmanex Twisthaler 60 Dose Consumer Information (Cerner Multum)
- Asmanex Twisthaler 7 Dose Consumer Information (Cerner Multum)
- Asmanex Twist Advanced Consumer Information (Micromedex)
- Asmanex Twisthaler Advanced Consumer Information (Micromedex)
- Asmanex AHFS DI Monographs (ASHP)
- Mometasone Powder Consumer Information (Wolters Kluwer)
- Mometasone inhalation Consumer Information (Cerner Multum)
- Azmax Twisthaler Advanced Consumer Information (Micromedex)
- Mometasone Inhalation, oral/nebulization Advanced Consumer Information (Micromedex)
- Mometasone Furoate AHFS DI Monographs (ASHP)
No comments:
Post a Comment